Pharmacokinetics of H002, a novel S1PR1 modulator, and its metabolites in rat blood utilizing liquid chromatography–tandem mass spectrometryH002 is often a precision therapeutic prospect to the therapy of NSCLC, with broad spectrum and significant selectivity versus various EGFR mutations including Individuals with EGFR C797S mutation.The loading